SelectQuote, Inc. (SLQT) SEC Filings & Earnings Calls

Pharmacy reimbursement rate risk

“the Compensation Committee recognized that the metrics may be disproportionately impacted by certain external risks, including pharmacy reimbursement rates” · word for word

NYSE continued listing risk

“On March 19, 2026, we were notified in writing by the NYSE that the average closing trading price of our common stock was below the criteria of the NYSE’s continued listing standards” · word for word

Senior segment revenue decline of 12% in Q4 and 4% for FY2026, with Medicare Advantage approved policies down 15% in Q4, indicating potential market share or carrier volume headwinds.

“Senior Revenue down 12% in Q4; Medicare Advantage approved policies down 15% in Q4.”

Consolidated net loss in Q4 vs net income prior year, driven by revenue decline and possibly higher costs.

“Net loss of $16.8M in Q4 2026 vs net income of $12.9M in Q4 2025.”

Regulatory Risk - Medicare Marketing and Compliance

“The regulations and guidance issued by CMS for Medicare Advantage and Medicare Part D Prescription Drug plans change frequently, and such changes...could cause healthcare providers or state departments of insurance to object to or decline to approve certain aspects of our marketing materials and processes.” · word for word

Concentration Risk - Insurance Carrier Partners

“Our reliance on a limited number of insurance carrier partners and pharmacy benefit managers and any potential termination of those relationships or failure to develop new relationships” · word for word

Seasonality Risk

“33% of total consolidated revenue being generated during the second quarter”

Litigation Risk - False Claims Act

“Potential litigation and other legal proceedings or inquiries, including the Department of Justice action alleging violations of the False Claims Act by us and other industry participants” · word for word

Healthcare Services margin pressure despite revenue growth

“Healthcare Services Adjusted EBITDA margin 3% flat YoY; Adjusted EBITDA down 18% YoY”

Medicare Advantage policy submission decline

“Submitted MA policies down 2% YoY in Q3 and 6% YTD”

High leverage and preferred stock obligations

“Senior Non-Convertible Preferred Stock with 14.5% dividend rate and $408.4M liquidation preference; total debt $375.8M.”

Seasonality and Medicare enrollment concentration

“Medicare-eligible individuals are permitted to change their Medicare Advantage and Medicare Part D Prescription Drug coverage for the following year during the Medicare annual enrollment period ('AEP') in October through December... As a result, the Senior segment’s revenue is highest in the second and third quarters.” · word for word

High leverage and preferred stock dividend burden

“Senior Non-Convertible Preferred Stock accumulated dividends and accretion (18,125) for the three months ended December 31, 2025.” · word for word

Seasonal revenue concentration in Senior segment

“As a result, the Senior segment’s revenue is highest in the second and third quarters.” · word for word

Guidance cut due to national carrier constraining MA marketing spend and PBM reimbursement changes.

“a national carrier’s decision to constrain additional MA policy volume by curtailing strategic marketing spend across all channels, and the previously communicated PBM reimbursement changes.” · word for word

Declining LTV per Medicare Advantage policy (-4% YoY) due to carrier mix and persistency changes.

“Lifetime value of commissions per approved policy: Medicare Advantage $874 vs $907 (-4%)”

Healthcare Services segment has very low Adj. EBITDA ($0.8M on $230.7M revenue), indicating early stage profitability.

“Healthcare Services: Adjusted EBITDA of $0.8 million”

Senior segment revenue and profitability decline due to Medicare Advantage eligibility changes.

“Senior revenue down 37% YoY; Adj. EBITDA margin -36% vs 8%.”

Healthcare Services segment faces temporary reimbursement rate headwind in SelectRx.

“Temporary reimbursement rate headwind impacting SelectRx; Adj. EBITDA expected near breakeven in Q2.”

Regulatory Risk - Medicare Advantage Enrollment

“The decrease was primarily driven by changes in regulations that limited special enrollment period eligibility and election opportunities for Medicare Advantage members outside of the standard AEP.” · word for word

Legal Risk - DOJ False Claims Act Investigation

“The complaints allege that the Company and the other defendants named therein violated the Federal False Claims Act by engaging in various allegedly improper sales and marketing practices.” · word for word

Liquidity Risk - Low Cash Balance and Operating Cash Burn

“Net cash used in operating activities was $21.6 million. Cash, cash equivalents, and restricted cash totaled $15.7 million as of September 30, 2025.” · word for word

LTV Deterioration Risk

“The LTV per MA approved policy decreased 5% ... primarily due to carrier mix and specific carriers shifting away from upfront payment contracts, combined with deterioration in persistency due to recent plan terminations.” · word for word